What is obstructive sleep apnea (OSA)?
During sleep the throat muscles relax; if the upper airway narrows or collapses, airflow weakens (hypopnea) or stops completely (apnea) for over 10 seconds. The brain briefly arouses to restart breathing, repeatedly disrupting sleep. The events-per-hour count is the Apnea-Hypopnea Index (AHI): 5–15 mild, 15–30 moderate, ≥ 30 severe. Prevalence has risen markedly, and many patients are unaware they have it.
6 warning signs to watch for
- Persistent loud snoring, sometimes with silent breathing pauses
- Gasping or choking awake at night
- Daytime sleepiness, dozing while driving or in meetings
- Morning headaches (from nocturnal hypoxia)
- Frequent night-time urination (often mistaken for a urinary issue)
- Poor focus and memory, irritability
The more signs and the longer they persist, the more advisable an AHI and blood-oxygen test becomes.
Health risks if left untreated
Repeated nocturnal hypoxia and sympathetic over-activation link untreated OSA to multiple chronic conditions: resistant hypertension (identified by the American Heart Association as a leading cause), cardiovascular disease and stroke, type 2 diabetes and metabolic syndrome, and erectile dysfunction in men. Daytime sleepiness raises crash risk 2–7×. Early diagnosis and treatment help reduce these risks.
When to see a doctor — and treatment options
If long-term snoring is combined with daytime sleepiness, or a partner notices breathing pauses, seek evaluation from a sleep or dental-sleep-medicine specialist and arrange a sleep study (PSG or home HSAT) to confirm severity. Treatment follows severity: CPAP is first-line for severe cases; for mild-to-moderate OSA or CPAP intolerance, oral appliance therapy (OAT) is the non-invasive option recommended by AASM/AADSM guidelines. OSAWELL is Taiwan's TFDA Class II custom medical-grade OAT. See our oral appliance vs CPAP vs surgery comparison.